References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Jarvisetal(2000)ABT-702(4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine),anovelorallyeffectiveadenosinekinaseinhibitorwithanalgesicandanti-inflammatoryproperties:IInvitrocharacterizationandacuteantinociceptiveJ.Pharmacol.Exp.Ther.2951156PMID:11082453
Kowaluketal(2000)ABT-702(4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine),anovelorallyeffectiveadenosinekinaseinhibitorwithanalgesicandanti-inflammatorypropertiesII.Invivocharacterizationintherat.J.Pharmacol.Exp.Ther.2951165PMID:11082454
Leeetal(2001)Discoveryof4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine,anorallyactive,non-nucleosideadenosinekinaseinhibitor.J.Med.Chem.442133PMID:11405650
Keywords:ABT702dihydrochloride,supplier,adenosines,kinases,inhibitors,inhibits,orally,active,ADK,Receptors,ABT702,dihydrochloride,Adenosine,Kinase,Other,Adenosine,Adenosine,Kinase,TocrisBioscience